3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Prostatic Neoplasms
4
Neuroendocrine Tumors
2
Lymphoma
2
Hodgkin Disease
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Smoking Cessation
1
Rectal Neoplasms
1
Prostate Cancer Metastatic
1
Neoplastic Cells, Circulating
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Leukemia
1
Hypoxia
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Lobular
1
Cancer Diagnosis
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Cyclophosphamide
59
Dexamethasone
56
Melphalan
48
Peripheral Blood Stem Cell Transplantation
37
Busulfan
34
Bortezomib
32
fludarabine phosphate
29
Lenalidomide
27
Filgrastim
27
Tacrolimus
24
Antilymphocyte Serum
24
Thalidomide
22
Mycophenolic Acid
22
Radiotherapy
21
Methotrexate
15
Cyclosporine
15
Etoposide
14
sargramostim
13
Granulocyte Colony-Stimulating Factor
11
Whole-Body Irradiation
10
Methylprednisolone
10
Interferon-alpha
10
fludarabine
9
daratumumab
9
Carmustine
9
carfilzomib
7
Rituximab
7
Prednisone
7
Cytarabine
7
Cord Blood Stem Cell Transplantation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplasms, Plasma Cell
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT03314636
2025-08-08
CONPET
Oslo University Hospital
Phase 2
Active not recruiting
53 enrolled